US Patent 10066016 Single chain variable fragment CD3 binding proteins
Patent 10066016 was granted and assigned to Harpoon Therapeutics on September, 2018 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10066016 Single chain variable fragment CD3 binding proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
